Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Share News (SYNC)

Share Price Information for Syncona (SYNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 110.40
Bid: 110.40
Ask: 111.20
Change: 0.40 (0.36%)
Spread: 0.80 (0.725%)
Open: 110.00
High: 111.20
Low: 110.00
Prev. Close: 110.00
SYNC Live PriceLast checked at -
Syncona is an Investment Trust

To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Omicron hope lifts FTSE despite UK virus surge

Wed, 22nd Dec 2021 17:03

(Alliance News) - Equity prices in London on Wednesday shook off news of fresh daily record coronavirus infections in the UK to end higher amid cautious optimism over the severity of the Omicron variant.

The FTSE 100 index closed up 44.25 points, or 0.6%, at 7,341.66. The FTSE 250 ended up 260.49 points, or 1.1%, at 23,080.79, and the AIM All-Share closed up 10.24 points, or 0.9%, at 1,183.81.

The Cboe UK 100 ended up 0.5% at 726.92, the Cboe UK 250 closed up 1.3% at 20478.57, and the Cboe Small Companies ended up 1.2% at 15004.11.

In European equities on Wednesday, the CAC 40 in Paris ended up 1.1% and the DAX 40 in Frankfurt ended up 1.0%.

Tentative optimism over the Omicron coronavirus variant supported markets on Wednesday.

"Some preliminary results from the UK Health & Security agency around the effects of the Omicron variant appear to be being received positively today. In line with South Africa's experience, it would appear that the Omicron variant does indeed appear to be milder, although the report also suggests that the higher infection rate could also place increased strain on hospitals, if enough people get it even if mortality is lower," said Michael Hewson, chief market analyst at CMC Markets.

"Nonetheless, it is still good news, and helps justify the move to delay a decision on new restrictions in England until after Christmas, and potentially allow greater leeway next week when restrictions could well change again."

UK Prime Minister Boris Johnson on Tuesday gave the go-ahead for people's Christmas plans, although he warned tougher restrictions could be implemented post-December 25.

However, Wales on Wednesday followed Scotland in unveiling new post-Christmas coronavirus curbs, primarily around hospitality and large events, as the UK's devolved nations move at different speeds to surging Omicron variant cases.

This came as the UK clocked another daily new cases record – 106,122 – as it announced it would buy millions of Covid pills, and also cut the isolation period for infected people from 10 to seven days with negative tests.

Sterling strengthened, however. The pound was quoted at USD1.3346 at the London equities close Wednesday, jumping from USD1.3248 at the close on Tuesday after some mixed gross domestic product data.

On the quarter before, UK gross domestic product advanced by 1.1% in the three months to September, slower than a 5.4% rise in the three months to July and missing consensus of an expansion of 1.3%, which would have matched the first estimate. On a year before, the UK economy grew by 6.8% in the third quarter, slightly beating the market forecast of 6.6% annual growth, which also would have matched the first estimate.

The ONS said the largest contributors to the increase in GDP were hospitality and arts, entertainment & recreation, following the further easing of restrictions and reopening of the economy during the period - something which could now be at risk given the Omicron wave.

Other countries have started to impose restrictions to curb the virus's spread. The Netherlands has already imposed a Christmas lockdown and Germany has slapped a limit of 10 people on private parties, closed nightclubs and banned spectators from major events including soccer matches.

Shaking this off, London-listed travel and leisure firms gained on Wednesday. Jet engine maker Rolls-Royce ended up 3.3% and Holiday Inn owner InterContinental Hotels Group rose 2.7%.

Pandemic-battered stocks also ended in the green in the mid-cap FTSE 250 index, with food and beverage outlets operator SSP Group rising 4.8% and Mitchells & Butlers up 2.7%.

Elsewhere, Taylor Wimpey rose 2.2% after committing to removing terms from contracts that double ground rents for leaseholders every 10 years.

Taylor Wimpey said the UK Competition & Markets Authority investigation into the historical sale of leasehold properties with doubling ground rent clauses by the company is closed, following the agreement of voluntary undertakings. The High Wycombe-based housebuilder said the cost of the undertakings falls within the original provision Taylor Wimpey made in 2017.

Syncona jumped 5.5% after the healthcare investor said its portfolio company Gyroscope Therapeutics will be sold to Swiss pharmaceutical maker Novartis for up to USD1.5 billion.

Syncona has a 54% stake in Gyroscope following a USD42 million investment in March, after co-founding the business in 2016. In a bumper payday, Syncona will receive upfront cash proceeds of GBP334 million from the deal, representing a GBP180 million uplift to the current holding value.

Stocks in New York were higher at the London equities close, with the DJIA up 0.5%, the S&P 500 index up 0.7%, and the Nasdaq Composite up 0.9%.

The dollar was on the back foot amid Wednesday's cautious optimism, failing to get a boost from an upwards revision to the US economy's performance in the third quarter.

On an annual basis, the US economy grew at a rate of 2.3% in the three months to September, slowing from a 6.7% expansion in the second quarter. The latest reading beat the market forecast of an expansion of 2.1%, however, which would have matched the second estimate.

The euro stood at USD1.1327 at the European equities close Wednesday, up against USD1.1267 at the same time on Tuesday.

Gold benefited from dollar weakness. The shining metal was quoted at USD1,797.90 an ounce at the London equities close Wednesday, rising from USD1,785.40 at the close on Tuesday.

However, the safe haven Japanese yen eased back. Against the yen, the dollar rose to JPY114.22 compared to JPY114.14 late Tuesday.

Brent oil was quoted at USD74.74 a barrel at the London equities close Wednesday, up from USD73.48 late Tuesday.

Thursday's economic calendar has German import prices at 0700 GMT and US initial jobless claims at 1330 GMT, alongside durable goods orders and core personal consumption expenditures due at the same time.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
10 Nov 2022 21:19

TRADING UPDATES: Zambeef expects profit jump; Mobile Streams wins deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
10 Nov 2022 15:52

UK earnings, trading statements calendar - next 7 days

Friday 11 November 
Beazley PLCHalf Year Results
Permanent TSB Group Holdings PLCTrading Statement
TheWorks.co.uk PLCTrading Statement
Urban Logistics REIT PLCHalf Year Results
Monday 14 November 
Atalaya Mining PLCQ3 Results
Biome Technologies PLCTrading Statement
Cake Box Holdings PLCHalf Year Results
Diversified Energy Co PLCTrading Statement
HgCapital Trust PLCQ3 Results
Informa PLCTrading Statement
Kainos Group PLCHalf Year Results
MySale Group PLCFull Year Results
S4 Capital PLCQ3 Results
SRT Marine Systems PLCHalf Year Results
Totally PLCHalf Year Results
Tuesday 15 November 
AdEPT Technology Group PLCHalf Year Results
BAE Systems PLCTrading Statement
Gear4Music PLCHalf Year Results
Imperial Brands PLCFull Year Results
Land Securities Group PLCHalf Year Results
Melrose Industries PLCTrading Statement
Ninety One PLC and LtdHalf Year Results
R&Q Insurance Holdings LtdQ1 Results
Speedy Hire PLCHalf Year Results
Vesuvius PLCTrading Statement
Vodafone Group PLCHalf Year Results
Wincanton PLCHalf Year Results
Workspace Group PLCHalf Year Results
Wednesday 16 November 
Aristocrat Leisure LtdFull Year Results
British Land Co PLCHalf Year Results
Castings PLCHalf Year Results
CMC Markets PLCHalf Year Results
Enteq Technologies PLCHalf Year Results
Experian PLCHalf Year Results
Mediclinic International PLCHalf Year Results
Premier Foods PLCHalf Year Results
Renold PLCHalf Year Results
Sage Group PLCFull Year Results
Schroder Global Real Estate SecuritiesHalf Year Results
Schroder Real Estate Investment Trust LtdHalf Year Results
SSE PLCHalf Year Results
Thursday 17 November 
Burberry Group PLCHalf Year Results
Close Brothers Group PLCTrading Statement
Fuller, Smith & Turner PLCHalf Year Results
Grainger PLCFull Year Results
Great Portland Estates PLCHalf Year Results
Halma PLCHalf Year Results
Integrated Diagnostics Holdings PLCQ3 Results
Intermediate Capital Group PLCHalf Year Results
International Distributions Services PLCHalf Year Results
Investec PLC and LtdHalf Year Results
Keller Group PLCTrading Statement
Mitie Group PLCHalf Year Results
Pershing Square Holdings LtdQ3 Results
Redcentric PLCHalf Year Results
Seraphim Space Investment Trust PLCQ1 Results
Spirax-Sarco Engineering PLCTrading Statement
Syncona LtdHalf Year Results
Tyman PLCTrading Statement
Virgin Money UK PLCFull Year Results
Zytronic PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
3 Nov 2022 11:50

Syncona portfolio firm Autolus Therapeutics widens quarterly loss

(Alliance News) - Syncona Ltd on Thursday noted that its portfolio company Autolus Therapeutics PLC had widened its third quarter loss as it continued to progress its candidate pipeline.

Read more
24 Oct 2022 08:53

Syncona to acquire retinal therapy firm Applied Genetic Technologies

(Alliance News) - Syncona Ltd on Monday it will expand its retinal gene therapy pipeline with the acquisition of a Florida-based biotechnology company.

Read more
24 Oct 2022 07:42

Syncona to buy US biotech AGTC for $23.5m

(Sharecast News) - Healthcare group Syncona said on Monday that it has agreed to buy US biotechnology firm Applied Genetic Technologies Corporation (AGTC) for around $23.5m, or $0.34 per share, in cash.

Read more
16 Aug 2022 10:06

Syncona confident after Q1 market volatility

(Sharecast News) - Healthcare investor Syncona reported net assets of £1.33bn at the end of its first quarter on Tuesday, or 197.9p per share, up from £1.31bn and 194.4p per share at the end of March.

Read more
16 Aug 2022 09:15

IN BRIEF: Syncona posts slight quarterly NAV rise on foreign exchange

Syncona Ltd - London-based investor in healthcare companies - Reports small quarterly net asset value rise on gain on foreign exchange. Net asset value per share at June 30 stands at 197.7 pence per share, up 1.7% from 194.4p at March 31.

Read more
9 Aug 2022 14:18

Syncona notes half-year results and studies of Freeline and Achilles

(Alliance News) - Syncona Ltd on Tuesday noted half-year results of its investees, Freeline Therapeutics Holdings PLC and Achilles Therapeutics PLC.

Read more
26 Jul 2022 15:57

UK shareholder meetings calendar - next 7 days

Wednesday 27 July 
Allied Minds PLCAGM
Caledonia Investments PLCAGM
De La Rue PLCAGM
FirstGroup PLCAGM
James Cropper PLCAGM
JPMorgan Japan Small Cap Growth & Income PLCAGM
Mode Global Holdings PLCAGM
Montanaro UK Smaller Cos Investment Trust PLCAGM
Motorpoint Group PLCAGM
Shield Therapeutics PLCAGM
Tatton Asset Management PLCAGM
Thursday 28 July 
B&M European Value Retail SAAGM
Braemar Shipping Services PLCAGM
CMC Markets PLCAGM
CMC Markets PLCGM re proposed related party transaction
CYBA PLCAGM
De La Rue PLCAGM
discoverIE Group PLCAGM
Eight Capital Partners PLCAGM
Eurasia Mining PLCAGM
GB Group PLCAGM
Global Smaller Companies Trust PLCAGM
Graft Polymer (UK) PLCAGM
Ingenta PLCAGM
Mediclinic International PLCAGM
Octopus Renewables Infrastructure Trust PLCGM re investing in offshore wind farms in core focus
Oxford Instruments PLCAGM
RentGuarantor Holdings PLCAGM
Tate & Lyle PLCAGM
Ted Baker PLCAGM
Friday 29 July 
Eneraqua Technologies PLCAGM
Global Ports Holding PLCGM re elections of Ajini and Iosifakis as directors
Palace Capital PLCAGM
ProCook Group PLCAGM
Record PLCAGM
Rogue Baron PLCAGM
Sirius Real Estate LtdAGM
Standard Chartered PLCGM re approving HY announcement, interim dividend
Monday 1 August 
Cranswick PLCAGM
Tuesday 2 August 
Caffyns PLCAGM
Syncona LtdAGM
Tanfield Group PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
11 Jul 2022 08:21

Syncona investee Freeline's gene therapy for haemophilia B tolerated

(Alliance News) - Syncona Ltd on Monday said investee Freeline Therapeutics Holdings PLC has presented partial safety and efficacy data from a phase I/II dose confirmation trial for FLT180a, a gene therapy for haemophilia B.

Read more
16 Jun 2022 10:12

Syncona records slight increase in net asset value, skips dividend

(Alliance News) - Syncona Ltd on Thursday reported a slight increase in net asset value, but a lower total return, as the value of its holdings fell due to market volatility, as the firm skipped its dividend again.

Read more
16 Jun 2022 07:27

Syncona reports flat year-end net assets

(Sharecast News) - Healthcare investment company Syncona reported flat year-end net assets of £1.31bn in its final results on Thursday.

Read more
10 Jun 2022 14:42

IN BRIEF: Syncona portfolio company sees "encouraging" early data

Syncona Ltd - London-based investor in healthcare companies - Announces that its portfolio company, Autolus Therapeutics PLC, has published new clinical data across multiple programmes. Autolus reports "positive" early safety and efficacy data from Auto4 in patients with T cell lymphoma and "encouraging" early safety and efficacy data from Auto1/22 in paediatric acute lymphoblastic leukaemia.

Read more
9 Jun 2022 15:55

UK earnings, trading statements calendar - next 7 days

Friday 10 June 
Industrials REIT LtdFull Year Results
Monday 13 June 
Augmentum Fintech PLCFull Year Results
Molten Ventures PLCFull Year Results
Sirius Real Estate LtdFull Year Results
Tuesday 14 June 
Ashtead Group PLCFull Year Results
Bellway PLCTrading Statement
CML Microsystems PLCFull Year Results
Crest Nicholson Holdings PLCHalf Year Results
discoverIE Group PLCFull Year Results
Driver Group PLCHalf Year Results
Ferguson PLCQ3 Results
FirstGroup PLCFull Year Results
iomart Group PLCFull Year Results
LoopUp Group PLCTrading Statement
Montanaro UK Smaller Cos Investment Trust PLCFull Year Results
OnTheMarket PLCFull Year Results
Oxford Instruments PLCFull Year Results
Paragon Banking Group PLCHalf Year Results
Renalytix PLCTrading Statement
Vianet Group PLCFull Year Results
Wednesday 15 June 
AO World PLCFull Year Results
Bloomsbury Publishing PLCFull Year Results
Castings PLCFull Year Results
Custodian REIT PLCFull Year Results
Allied Minds PLCFull Year Results
Tatton Asset Management PLCFull Year Results
FireAngel Safety Technology Group PLCTrading Statement
Idox PLCHalf Year Results
IGas Energy PLCTrading Statement
JPMorgan European Discovery Trust PLCFull Year Results
Motorpoint Group PLCFull Year Results
SCS Group PLCTrading Statement
Severfield PLCFull Year Results
WH Smith PLCQ3 Trading Update
Whitbread PLCTrading Statement
Thursday 16 June 
Best of the Best PLCFull Year Results
boohoo Group PLCTrading Statement
CareTech Holdings PLCHalf Year Results
Filtronic PLCTrading Statement
GB Group PLCFull Year Results
Halfords Group PLCFull Year Results
Halma PLCFull Year Results
JLEN Environmental Assets Group LtdFull Year Results
Lindsell Train Investment Trust PLCFull Year Results
Momentum Multi-Asset Value Trust PLCFull Year Results
Mountview Estates PLCFull Year Results
N Brown Group PLCTrading Statement
NextEnergy Solar Fund LtdFull Year Results
River & Mercantile UK Micro Cap Investment Co LtdHalf Year Results
S4 Capital PLCTrading Statement
Syncona LtdFull Year Results
Volex PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
18 May 2022 13:01

Syncona invests USD54 million in SwanBio Therapeutics funding round

(Alliance News) - Syncona Ltd said on Wednesday it invested USD54 million in neurological disorder-focused gene therapy company SwanBio Therapeutics' Series B financing round.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.